Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center

Journal of Cardiovascular Medicine

Volumn 13, Issue 11, 2012, Pages 708-715

  Khalili, Hossein ^a   Talasaz, Azita Hajhossein ^a   Jenab, Yaser ^b   Salarifar, Mojtaba ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Emergency Department   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cardiovascular disease; diabetes; prevention; risk factors

Indexed keywords

STREPTOKINASE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CHEMISTRY; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; DRUG USE; ELECTROCARDIOGRAM; FEMALE; FRAMINGHAM RISK SCORE; GROUPS BY AGE; HEART ARRHYTHMIA; HEMODYNAMIC MONITORING; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; IRAN; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY DELAY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; COMORBIDITY; CORONARY ANGIOGRAPHY; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALS, TEACHING; HUMANS; HYPERTENSION; IRAN; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; STREPTOKINASE; THROMBOLYTIC THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84869871804     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328356a3c6     Document Type: Article

References (39)

1. Mendis S, Lindholm LH, Mancia G, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 2007; 25:1578-1582. (Pubitemid 47056562)
2. Khosravi A, Taylor R, Naghavi M, et al. Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ 2007; 85:607-614. (Pubitemid 47328204)
3. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, et al. Prevalence of coronary artery disease risk factors in Iran: a population based study. BMC Cardiovasc Disord 2007; 7:32.
4. Sadowski M, Gasior M, Gierlotka M, et al. Clinical characteristics of Polish women with ST-segment elevation myocardial infarction. Kardiol Pol 2010; 68:627-634.
5. Parodi G, Bellandi B, Valenti R, et al. Heart rate as an independent prognostic risk factor in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Atherosclerosis 2010; 211:255-259.
6. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptomonset- to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283:2941-2947. (Pubitemid 30414505)
7. McNamara RL, Wang Y, Herrin J, et al. Effect of door to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006; 47:2180-2186. (Pubitemid 43810139)
8. Kotowycz MA, Cosman TL, Tartaglia C, et al. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction: a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial). Am Heart J 2010; 159: 117.e1-e6.
9. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673-682.
10. Sinnaeve P, Alexander J, Belmans A, et al. Randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction. Am Heart J 2003; 146:27- 32. (Pubitemid 36851296)
11. Trigo J, Mimoso J, Gago P, et al. Female gender: an independent factor in ST-elevation myocardial infarction. Rev Port Cardiol 2010; 29:1383-
12. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572. (Pubitemid 37430158)
13. Franco OH, Peeters A, Bonneux L, et al. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women life course analysis. Hypertension 2005; 46:280-286. (Pubitemid 41099158)
14. Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial. Lancet 2008; 372:817-821.
15. Goldberg RJ, Steg PG, Sadiq I, et al. Extent of and factors associated with delay to hospital presentation in patients with acute coronary disease (The GRACE Registry). Am J Cardiol 2002; 89:791-796. (Pubitemid 34241453)
16. Dracup K, Moser DK, Eisenberg M, et al. Causes of delay in seeking treatment for heart attack symptoms. Soc Sci Med 1995; 40:379-392.
17. Goldberg RJ, Yarzebski JL, Lessard DM, et al. Decade long trends (1986- 1997), and factors associated with, time to hospital presentation in patients with acute myocardial infarction (The Worcester Heart Attack Study). Arch Intern Med 2000; 160:3217-3223.
18. Gibson CM, Pride YB, Frederick PD, et al. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008; 156:1035-1044.
19. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24:28-66.
20. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44:E1-E211.
21. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of randomized trials. Lancet 2003; 361:13-20. (Pubitemid 36050955)
22. Alidoosti M, Salarifar M, Hajizeinali A, et al. Outcomes of primary percutaneous coronary intervention in acute myocardial infarction at Tehran Heart Center. Med Princ Pract 2007; 16:333-338. (Pubitemid 47298141)
23. Rugulies R. Depression as a predictor for coronary heart disease a review and meta-analysis. Am J Prev Med 2002; 23:51-61. (Pubitemid 34687133)
24. Yary T, Soleimannejad K, Abd Rahim F, et al. Contribution of diet and major depression to incidence of acute myocardial infarction (AMI). Lipids Health Dis 2010; 9:133.
25. Thomson SP, Gibbons RJ, Smars PA, et al. Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann Intern Med 1995; 122:335- 341.
26. Menon V, Lessard D, Yarzebski J, et al. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol 2003; 92:368- 372. (Pubitemid 36959869)
27. Grzybowski M, Welch RD, Parsons L, et al. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med 2004; 11:1049-1060. (Pubitemid 39244000)
28. Paul GK, Sen B, Bari MA, et al. Correlation of platelet count and acute STelevation in myocardial infarction. Mymensingh Med J 2010; 19:469-473.
29. Cemin R, Donazzan L, Lippi G, et al. Blood cells characteristics as determinants of acute myocardial infarction. Clin Chem Lab Med 2011; 49:1231-1236.
30. Lazzeri C, Valente S, Tarquini R, et al. Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty. Med Sci Monit 2010; 16:CR567-CR574.
31. Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25:1880- 1890. (Pubitemid 39452604)
32. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359:2140-2144. (Pubitemid 34694020)
33. Høfsten DE, Løgstrup BB, Møller JE, et al. Abnormal glucose metabolism in acute myocardial infarction influence on left ventricular function and prognosis. J Am Coll Cardiol Img 2009; 2:592-599.
34. Franco OH, Steyerberg EW, Hu FB, et al. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 2007; 167:1145-1151. (Pubitemid 46924742)
35. Stone PH, Muller JE, Hartwell T, et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989; 14:49-57. (Pubitemid 19165535)
36. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847. (Pubitemid 28213628)
37. Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13:745-753. (Pubitemid 34183941)
38. Walsh CR, O' Donnell CJ, Camargo CA Jr, et al. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 2002; 144:1003-1011. (Pubitemid 36026913)
39. Naito K, Anzai T, Yoshikawa T, et al. Impact of chronic kidney disease on post infarction inflammation, oxidative stress and left ventricular remodeling. J Cardiac Fail 2008; 14:831-838.